- 专利标题： Humanized antibodies to TNF-like ligand 1A (TL1A) and uses thereof
-
申请号： US17682922申请日： 2022-02-28
-
公开(公告)号： US11999789B2公开(公告)日： 2024-06-04
- 发明人: Jeffry D. Watkins , Cindy T. Dickerson , Rafael Rojas , Matthew Reissman , Patricia McNeeley , Janine Bilsborough , Bradley Henkle , Stephan R. Targan
- 申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER
- 申请人地址： US CA San Diego
- 专利权人： PROMETHEUS BIOSCIENCES, INC.,CEDARS-SINAI MEDICAL CENTER
- 当前专利权人： PROMETHEUS BIOSCIENCES, INC.,CEDARS-SINAI MEDICAL CENTER
- 当前专利权人地址： US CA San Diego; US CA Los Angeles
- 代理机构： Wilson Sonsini Goodrich & Rosati
- 分案原申请号： US17110004 2020.12.02
- 主分类号： C07K16/24
- IPC分类号： C07K16/24 ; A61P1/04 ; C07K16/28 ; A61K39/395 ; C07K14/52 ; C07K14/525
摘要：
Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).
公开/授权文献
信息查询
